PMC:7091888 / 21585-22720
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
909 | 126-130 | Gene | denotes | ACE2 | Gene:59272 |
910 | 244-248 | Gene | denotes | ACE2 | Gene:59272 |
911 | 398-402 | Gene | denotes | ACE2 | Gene:59272 |
912 | 303-304 | Gene | denotes | S | Gene:43740568 |
913 | 38-48 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
914 | 146-151 | Species | denotes | human | Tax:9606 |
915 | 254-262 | Species | denotes | SARS-CoV | Tax:694009 |
916 | 268-278 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
917 | 322-332 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
918 | 349-357 | Species | denotes | SARS-CoV | Tax:694009 |
919 | 465-475 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
920 | 537-547 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
921 | 552-560 | Species | denotes | SARS-CoV | Tax:694009 |
922 | 562-570 | Species | denotes | SARS-CoV | Tax:694009 |
923 | 617-627 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
924 | 703-711 | Species | denotes | SARS-CoV | Tax:694009 |
925 | 802-810 | Species | denotes | SARS-CoV | Tax:694009 |
926 | 826-836 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
927 | 960-970 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
928 | 1088-1098 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
929 | 653-685 | Disease | denotes | SARS-CoV-2 pseudovirus infection | MESH:C000657245 |
930 | 765-785 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
931 | 974-992 | Disease | denotes | SARS-CoV infection | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T167 | 53-60 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T168 | 98-102 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T169 | 177-184 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T170 | 283-290 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T171 | 305-312 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T172 | 430-435 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T173 | 480-487 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T174 | 815-822 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T175 | 841-848 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T395 | 38-46 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T396 | 38-42 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T397 | 254-262 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T398 | 254-258 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T399 | 268-276 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T400 | 268-272 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T401 | 322-330 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T402 | 322-326 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T403 | 349-357 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T404 | 349-353 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T405 | 465-473 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T406 | 465-469 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T407 | 537-545 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T408 | 537-541 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T409 | 552-560 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T410 | 552-556 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T411 | 562-570 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T412 | 562-566 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T413 | 617-625 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T414 | 617-621 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T415 | 653-661 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T416 | 653-657 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T417 | 676-685 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T418 | 703-711 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T419 | 703-707 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T420 | 765-773 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T421 | 765-769 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T422 | 776-785 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T423 | 802-810 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T424 | 802-806 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T425 | 826-834 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T426 | 826-830 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T427 | 960-968 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T428 | 960-964 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T429 | 974-992 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T430 | 974-978 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T431 | 983-992 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T432 | 1088-1096 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T433 | 1088-1092 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T389 | 98-102 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T390 | 146-151 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T391 | 156-159 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bat |
T392 | 430-435 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T393 | 491-492 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T394 | 864-865 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T87 | 53-60 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T88 | 177-184 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T89 | 283-290 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T90 | 305-312 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T91 | 480-487 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T92 | 519-528 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T93 | 815-822 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T94 | 841-848 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T130 | 0-167 | Sentence | denotes | In summary, we have characterized the SARS-CoV-2 RBD protein which exhibits strong binding to its cell-associated and soluble ACE2 receptors with human and bat origin. |
T131 | 168-267 | Sentence | denotes | This RBD protein also demonstrated significantly higher binding affinity to ACE2 than SARS-CoV RBD. |
T132 | 268-561 | Sentence | denotes | SARS-CoV-2 RBD protein could block S protein-mediated SARS-CoV-2 pseudovirus and SARS-CoV pseudovirus entry into their respective ACE2 receptor-expressing target cells, suggesting the potential of SARS-CoV-2 RBD protein as a viral attachment or entry inhibitor against SARS-CoV-2 and SARS-CoV. |
T133 | 562-993 | Sentence | denotes | SARS-CoV RBD-induced antibodies could cross-react with SARS-CoV-2 RBD and cross-neutralize SARS-CoV-2 pseudovirus infection, indicating that SARS-CoV RBD-specific antibodies may be used for treatment of SARS-CoV-2 infection and that either SARS-CoV RBD protein or SARS-CoV-2 RBD protein may be used as a candidate vaccine to induce cross-reactive or cross-neutralizing antibodies for prevention of SARS-CoV-2 or SARS-CoV infection. |
T134 | 994-1135 | Sentence | denotes | Taken together, this study provides an essential foundation for the design and development of SARS-CoV-2 RBD-based vaccines and therapeutics. |